Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies

Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies

Anastasia Gkiala,1 Sotiria Palioura2 1National and Kapodistrian University of Athens School of Medicine, Athens, Greece; 2Athens Vision Eye Institute, Athens, GreeceCorrespondence: Sotiria PaliouraAthens Vision Eye Institute, 328-330 Syngrou Ave., Kallithea, Athens 17673, GreeceTel +30 698 580 2355E...

Full description

Bibliographic Details
Main Authors: Gkiala A, Palioura S
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Clinical Ophthalmology
Subjects:
immune checkpoint inhibitors
braf inhibitors
mek inhibitors
ctla4 inhibitors
pd1 inhibitors
c-kit mutations
braf mutations
nras mutations
dabrafenib
vemurafenib
trametinib
ipilimumab
pembrolizumab
nivolumab
Online Access:https://www.dovepress.com/conjunctival-melanoma-update-on-genetics-epigenetics-and-targeted-mole-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/conjunctival-melanoma-update-on-genetics-epigenetics-and-targeted-mole-peer-reviewed-article-OPTH

Similar Items